Trial Profile
Study of Treat and Extend Regimen using Aflbercept for macular edema (CRVO-ME) associated with central retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 15 Mar 2018 New trial record